Stock Analysts’ new coverage for Thursday, February 27th:
StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE). The firm issued a sell rating on the stock.
StockNews.com initiated coverage on shares of Bank of South Carolina (NASDAQ:BKSC). StockNews.com issued a sell rating on the stock.
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF). They issued a sell rating on the stock.
TD Cowen assumed coverage on shares of Certara (NASDAQ:CERT). The firm issued a buy rating and a $16.00 target price on the stock.
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS). The firm issued a buy rating on the stock.
StockNews.com started coverage on shares of ClearOne (NASDAQ:CLRO). StockNews.com issued a hold rating on the stock.
Stifel Nicolaus started coverage on shares of COMPASS Pathways (NASDAQ:CMPS). Stifel Nicolaus issued a buy rating and a $11.00 target price on the stock.
StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC). They issued a sell rating on the stock.
StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ). StockNews.com issued a hold rating on the stock.
StockNews.com started coverage on shares of Fiserv (NASDAQ:FISV). They issued a buy rating on the stock.
StockNews.com began coverage on shares of Fluent (NASDAQ:FLNT). StockNews.com issued a hold rating on the stock.
StockNews.com started coverage on shares of Global Indemnity Group (NASDAQ:GBLI). They issued a buy rating on the stock.
Wells Fargo & Company initiated coverage on shares of Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI). Wells Fargo & Company issued an overweight rating and a $33.00 price target on the stock.
StockNews.com initiated coverage on shares of Heartland Financial USA (NASDAQ:HTLF). StockNews.com issued a hold rating on the stock.
TD Cowen initiated coverage on shares of Disc Medicine (NASDAQ:IRON). TD Cowen issued a buy rating on the stock.
StockNews.com initiated coverage on shares of Nordstrom (NYSE:JWN). They issued a buy rating on the stock.
StockNews.com initiated coverage on shares of Manhattan Bridge Capital (NASDAQ:LOAN). StockNews.com issued a strong-buy rating on the stock.
StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP). They issued a buy rating on the stock.
StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV). They issued a hold rating on the stock.
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB). They issued a sell rating on the stock.
StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV). The firm issued a hold rating on the stock.
Piper Sandler began coverage on shares of Plumas Bancorp (NASDAQ:PLBC). The firm issued an overweight rating and a $60.00 price target on the stock.
StockNews.com began coverage on shares of Qurate Retail (NASDAQ:QRTEA). They issued a hold rating on the stock.
StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA). They issued a sell rating on the stock.
StockNews.com began coverage on shares of Riverview Bancorp (NASDAQ:RVSB). They issued a hold rating on the stock.
StockNews.com started coverage on shares of comScore (NASDAQ:SCOR). They issued a hold rating on the stock.
Barclays PLC assumed coverage on shares of Super Micro Computer (NASDAQ:SMCI). Barclays PLC issued an equal weight rating and a $59.00 price target on the stock.
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE). StockNews.com issued a hold rating on the stock.
StockNews.com assumed coverage on shares of Shutterstock (NYSE:SSTK). StockNews.com issued a hold rating on the stock.
StockNews.com assumed coverage on shares of Top Ships (NASDAQ:TOPS). StockNews.com issued a hold rating on the stock.
StockNews.com began coverage on shares of USD Partners (NYSE:USDP). The firm issued a hold rating on the stock.
StockNews.com assumed coverage on shares of Xcel Brands (NASDAQ:XELB). They issued a sell rating on the stock.
Receive News & Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
